AMZEEQ Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Amzeeq, and when can generic versions of Amzeeq launch?
Amzeeq is a drug marketed by Journey and is included in one NDA. There are twelve patents protecting this drug and one Paragraph IV challenge.
This drug has twenty-five patent family members in ten countries.
The generic ingredient in AMZEEQ is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Amzeeq
A generic version of AMZEEQ was approved as minocycline hydrochloride by WATSON LABS on December 30th, 1991.
Summary for AMZEEQ
International Patents: | 25 |
US Patents: | 12 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 95 |
Clinical Trials: | 1 |
Patent Applications: | 3,003 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for AMZEEQ |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for AMZEEQ |
What excipients (inactive ingredients) are in AMZEEQ? | AMZEEQ excipients list |
DailyMed Link: | AMZEEQ at DailyMed |
Recent Clinical Trials for AMZEEQ
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Edward Lain, MD | Phase 4 |
Vyne Therapeutics Inc. | Phase 4 |
Pharmacology for AMZEEQ
Drug Class | Tetracycline-class Drug |
Physiological Effect | Decreased Prothrombin Activity |
Anatomical Therapeutic Chemical (ATC) Classes for AMZEEQ
Paragraph IV (Patent) Challenges for AMZEEQ
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
AMZEEQ | Topical Aerosol Foam | minocycline hydrochloride | 4% | 212379 | 1 | 2021-05-11 |
US Patents and Regulatory Information for AMZEEQ
AMZEEQ is protected by twelve US patents.
Patents protecting AMZEEQ
Topical tetracycline compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS
Topical tetracycline compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS
Compositions, gels and foams with rheology modulators and uses thereof
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Compositions and methods for treating rosacea and acne
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS
Method for healing of an infected acne lesion without scarring
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS
Compositions and methods for treating rosacea and acne
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS
Topical tetracycline compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS
Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Topical tetracycline compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS
Topical tetracycline compositions
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF NON-NODULAR ACNE VULGARIS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Journey | AMZEEQ | minocycline hydrochloride | AEROSOL, FOAM;TOPICAL | 212379-001 | Oct 18, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Journey | AMZEEQ | minocycline hydrochloride | AEROSOL, FOAM;TOPICAL | 212379-001 | Oct 18, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Journey | AMZEEQ | minocycline hydrochloride | AEROSOL, FOAM;TOPICAL | 212379-001 | Oct 18, 2019 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for AMZEEQ
See the table below for patents covering AMZEEQ around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Mexico | 359879 | COMPOSICIONES TÓPICAS DE TETRACICLINA. (TOPICAL TETRACYCLINE COMPOSITIONS.) | ⤷ Try a Trial |
United Kingdom | 201016546 | ⤷ Try a Trial | |
Israel | 218865 | תכשירי טטרציקלין לשימוש מקומי (Topical tetracycline compositions) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |